US Bancorp’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.3M | Sell |
5,735
-512
| -8% | -$91.2K | ﹤0.01% | 1071 |
|
|
2026
Q1 | $1.08M | Sell |
6,247
-1,276
| -17% | -$237K | ﹤0.01% | 1108 |
|
|
2025
Q4 | $1.5M | Buy |
7,523
+1,958
| +35% | +$355K | ﹤0.01% | 994 |
|
|
2025
Q3 | $871K | Buy |
5,565
+214
| +4% | +$34K | ﹤0.01% | 1207 |
|
|
2025
Q2 | $812K | Sell |
5,351
-2,960
| -36% | -$395K | ﹤0.01% | 1216 |
|
|
2025
Q1 | $1.25M | Sell |
8,311
-837
| -9% | -$140K | ﹤0.01% | 1027 |
|
|
2024
Q4 | $1.69M | Sell |
9,148
-4,578
| -33% | -$882K | ﹤0.01% | 926 |
|
|
2024
Q3 | $2.7M | Sell |
13,726
-7,851
| -36% | -$1.63M | ﹤0.01% | 761 |
|
|
2024
Q2 | $4.46M | Sell |
21,577
-223
| -1% | -$50.5K | 0.01% | 603 |
|
|
2024
Q1 | $5.91M | Sell |
21,800
-2,863
| -12% | -$684K | 0.01% | 541 |
|
|
2023
Q4 | $5.83M | Sell |
24,663
-1,719
| -7% | -$338K | 0.01% | 538 |
|
|
2023
Q3 | $5.17M | Buy |
26,382
+613
| +2% | +$126K | 0.01% | 540 |
|
|
2023
Q2 | $5.42M | Sell |
25,769
-1,419
| -5% | -$282K | 0.01% | 539 |
|
|
2023
Q1 | $5.49M | Sell |
27,188
-10,037
| -27% | -$2.27M | 0.01% | 535 |
|
|
2022
Q4 | $8.11M | Sell |
37,225
-410
| -1% | -$89.5K | 0.01% | 447 |
|
|
2022
Q3 | $7.41M | Buy |
37,635
+10,984
| +41% | +$2.37M | 0.02% | 425 |
|
|
2022
Q2 | $5.7M | Buy |
26,651
+143
| +0.5% | +$34.9K | 0.01% | 503 |
|
|
2022
Q1 | $7.53M | Buy |
26,508
+2,436
| +10% | +$751K | 0.01% | 476 |
|
|
2021
Q4 | $9.07M | Buy |
24,072
+205
| +0.9% | +$79.6K | 0.01% | 441 |
|
|
2021
Q3 | $9.85M | Sell |
23,867
-94
| -0.4% | -$39K | 0.02% | 406 |
|
|
2021
Q2 | $8.86M | Sell |
23,961
-104
| -0.4% | -$34.7K | 0.02% | 433 |
|
|
2021
Q1 | $6.97M | Buy |
24,065
+292
| +1% | +$81.2K | 0.01% | 477 |
|
|
2020
Q4 | $5.94M | Sell |
23,773
-1,167
| -5% | -$278K | 0.01% | 489 |
|
|
2020
Q3 | $5.65M | Sell |
24,940
-1,424
| -5% | -$296K | 0.01% | 469 |
|
|
2020
Q2 | $4.6M | Sell |
26,364
-1,610
| -6% | -$257K | 0.01% | 501 |
|
|
2020
Q1 | $3.53M | Buy |
27,974
+1,937
| +7% | +$291K | 0.01% | 518 |
|
|
2019
Q4 | $3.98M | Sell |
26,037
-1,958
| -7% | -$271K | 0.01% | 578 |
|
|
2019
Q3 | $3.71M | Buy |
27,995
+523
| +2% | +$70.1K | 0.01% | 584 |
|
|
2019
Q2 | $3.9M | Buy |
27,472
+2,790
| +11% | +$378K | 0.01% | 573 |
|
|
2019
Q1 | $3.59M | Sell |
24,682
-1,681
| -6% | -$221K | 0.01% | 570 |
|
|
2018
Q4 | $2.98M | Sell |
26,363
-2,144
| -8% | -$268K | 0.01% | 596 |
|
|
2018
Q3 | $3.83M | Sell |
28,507
-139
| -0.5% | -$17.2K | 0.01% | 583 |
|
|
2018
Q2 | $3.22M | Sell |
28,646
-1,639
| -5% | -$177K | 0.01% | 633 |
|
|
2018
Q1 | $3.23M | Buy |
30,285
+5,867
| +24% | +$632K | 0.01% | 629 |
|
|
2017
Q4 | $2.67M | Buy |
24,418
+6,203
| +34% | +$675K | 0.01% | 682 |
|
|
2017
Q3 | $1.97M | Buy |
18,215
+15,448
| +558% | +$1.59M | 0.01% | 794 |
|
|
2017
Q2 | $281K | Hold |
2,767
| – | – | ﹤0.01% | 1675 |
|
|
2017
Q1 | $248K | Sell |
2,767
-67
| -2% | -$5.69K | ﹤0.01% | 1714 |
|
|
2016
Q4 | $217K | Buy |
2,834
+112
| +4% | +$8.51K | ﹤0.01% | 1757 |
|
|
2016
Q3 | $227K | Sell |
2,722
-156
| -5% | -$13.1K | ﹤0.01% | 1702 |
|
|
2016
Q2 | $237K | Sell |
2,878
-243
| -8% | -$20K | ﹤0.01% | 1644 |
|
|
2016
Q1 | $236K | Sell |
3,121
-17
| -0.5% | -$1.26K | ﹤0.01% | 1621 |
|
|
2015
Q4 | $252K | Sell |
3,138
-687
| -18% | -$49.5K | ﹤0.01% | 1597 |
|
|
2015
Q3 | $243K | Sell |
3,825
-2,070
| -35% | -$149K | ﹤0.01% | 1641 |
|
|
2015
Q2 | $414K | Sell |
5,895
-1,196
| -17% | -$88.5K | ﹤0.01% | 1438 |
|
|
2015
Q1 | $562K | Sell |
7,091
-184
| -3% | -$13.6K | ﹤0.01% | 1305 |
|
|
2014
Q4 | $463K | Buy |
7,275
+795
| +12% | +$49.8K | ﹤0.01% | 1364 |
|
|
2014
Q3 | $387K | Buy |
6,480
+2,089
| +48% | +$120K | ﹤0.01% | 1447 |
|
|
2014
Q2 | $235K | Buy |
4,391
+595
| +16% | +$32.6K | ﹤0.01% | 1726 |
|
|
2014
Q1 | $229K | Buy |
3,796
+452
| +14% | +$26.3K | ﹤0.01% | 1704 |
|
|
2013
Q4 | $177K | Sell |
3,344
-4,338
| -56% | -$218K | ﹤0.01% | 1793 |
|
|
2013
Q3 | $355K | Buy |
7,682
+4,887
| +175% | +$224K | ﹤0.01% | 1404 |
|
|
2013
Q2 | $115K | Buy |
+2,795
| New | +$120K | ﹤0.01% | 1947 |
|
Other funds holding CRL
AI
US Bancorp's CRL Position: Q2 2026 in Review
US Bancorp reduced its Charles River Laboratories (CRL) stake by 8.2% in Q2 2026, selling an estimated $91.2K and leaving 5,735 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1071.
US Bancorp first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.85M in Q3 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- US Bancorp held 5,735 shares of Charles River Laboratories worth $1.3M as of Q2 2026.
- US Bancorp sold 512 Charles River Laboratories shares in Q2 2026, an estimated $91.2K.
- Charles River Laboratories made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1071 holding.
- US Bancorp first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's Charles River Laboratories position peaked at $9.85M in Q3 2021.
- 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.